Pneumonia Unveiled A Comprehensive Exploration of Causes, Symptoms, and Prevention

A major contributor to atypical community-acquired pneumonia, Mycoplasma pneumoniae poses a special challenge in the clinical and scientific arenas because of its unique features, which include its tiny genome size, absence of a cell wall, and capacity to elude host immune responses. The many aspects of Mycoplasma pneumoniae infections, including epidemiology, etiology, clinical symptoms, and diagnostic methods, are thoroughly reviewed in this study. A critical examination of existing treatment techniques and emerging therapeutic options is presented, coupled with an exploration of the changing terrain of antibiotic resistance in strains of Mycoplasma pneumoniae. Comprehensive knowledge of this sneaky pathogen is aided by insights into immune evasion mechanisms, host-pathogen interactions, and the function of Mycoplasma pneumoniae in chronic respiratory infections. This review is a useful resource for physicians, researchers, and other healthcare professionals by combining current scientific findings with clinical viewpoints. Keywords: Mycoplasma pneumoniae; Respiratory illness; COVID-19; Epidemics

Authors

Publication Details

Journal
Journal of Pharmaceutical Research
Published
2024-12-18
DOI
https://doi.org/10.18579/jopcr/v23.4.84
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pneumonia Unveiled A Comprehensive Exploration of Causes, Symptoms, and Prevention

Shruti Menon, Rajvi J. Wani, Dhanpat Jain, Samit S. Roy
Journal of Pharmaceutical Research
Pneumonia and Respiratory Infections
article

Pneumonia Unveiled A Comprehensive Exploration of Causes, Symptoms, and Prevention

Shruti Menon, Rajvi J. Wani, Dhanpat Jain, Samit S. Roy
article en

Abstract

A major contributor to atypical community-acquired pneumonia, Mycoplasma pneumoniae poses a special challenge in the clinical and scientific arenas because of its unique features, which include its tiny genome size, absence of a cell wall, and capacity to elude host immune responses. The many aspects of Mycoplasma pneumoniae infections, including epidemiology, etiology, clinical symptoms, and diagnostic methods, are thoroughly reviewed in this study. A critical examination of existing treatment techniques and emerging therapeutic options is presented, coupled with an exploration of the changing terrain of antibiotic resistance in strains of Mycoplasma pneumoniae. Comprehensive knowledge of this sneaky pathogen is aided by insights into immune evasion mechanisms, host-pathogen interactions, and the function of Mycoplasma pneumoniae in chronic respiratory infections. This review is a useful resource for physicians, researchers, and other healthcare professionals by combining current scientific findings with clinical viewpoints. Keywords: Mycoplasma pneumoniae; Respiratory illness; COVID-19; Epidemics

Journal of Pharmaceutical ResearchVol. 23(4)
Openalex Percentile: Top 60%
Pneumonia and Respiratory Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.